ALS Genes in the Genomic Era and their Implications for FTD
- PMID: 29605155
- DOI: 10.1016/j.tig.2018.03.001
ALS Genes in the Genomic Era and their Implications for FTD
Abstract
Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease, characterized genetically by a disproportionately large contribution of rare genetic variation. Driven by advances in massive parallel sequencing and applied on large patient-control cohorts, systematic identification of these rare variants that make up the genetic architecture of ALS became feasible. In this review paper, we present a comprehensive overview of recently proposed ALS genes that were identified based on rare genetic variants (TBK1, CHCHD10, TUBA4A, CCNF, MATR3, NEK1, C21orf2, ANXA11, TIA1) and their potential relevance to frontotemporal dementia genetic etiology. As more causal and risk genes are identified, it has become apparent that affected individuals can carry multiple disease-associated variants. In light of this observation, we discuss the oligogenic architecture of ALS. To end, we highlight emerging key molecular processes and opportunities for therapy.
Keywords: amyotrophic lateral sclerosis; frontotemporal dementia; genetics; genomics; oligogenic; therapy.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients.Neurobiol Aging. 2017 Mar;51:177.e9-177.e16. doi: 10.1016/j.neurobiolaging.2016.12.008. Epub 2016 Dec 21. Neurobiol Aging. 2017. PMID: 28069311
-
TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.Neurobiol Aging. 2015 Nov;36(11):3116.e5-3116.e8. doi: 10.1016/j.neurobiolaging.2015.08.009. Epub 2015 Aug 14. Neurobiol Aging. 2015. PMID: 26476236
-
Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.Mol Neurobiol. 2022 Sep;59(9):5673-5694. doi: 10.1007/s12035-022-02934-z. Epub 2022 Jun 30. Mol Neurobiol. 2022. PMID: 35768750 Review.
-
Mutations of CCNF gene is rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia from Mainland China.Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):265-268. doi: 10.1080/21678421.2017.1293111. Epub 2017 Mar 10. Amyotroph Lateral Scler Frontotemporal Degener. 2017. PMID: 28281833
-
[Genetic architecture of amyotrophic lateral sclerosis and frontotemporal dementia : Overlap and differences].Nervenarzt. 2017 Jul;88(7):728-735. doi: 10.1007/s00115-017-0349-4. Nervenarzt. 2017. PMID: 28573364 Review. German.
Cited by
-
The Links between ALS and NF-κB.Int J Mol Sci. 2021 Apr 8;22(8):3875. doi: 10.3390/ijms22083875. Int J Mol Sci. 2021. PMID: 33918092 Free PMC article. Review.
-
Amyotrophic lateral sclerosis.Lancet. 2022 Oct 15;400(10360):1363-1380. doi: 10.1016/S0140-6736(22)01272-7. Epub 2022 Sep 15. Lancet. 2022. PMID: 36116464 Free PMC article. Review.
-
Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches.Int J Mol Sci. 2024 Feb 15;25(4):2320. doi: 10.3390/ijms25042320. Int J Mol Sci. 2024. PMID: 38396996 Free PMC article. Review.
-
Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis.J Neuroinflammation. 2021 Jun 12;18(1):132. doi: 10.1186/s12974-021-02184-1. J Neuroinflammation. 2021. PMID: 34118929 Free PMC article.
-
Targeted inCITE-Seq Analysis Identifies the Loss of Nuclear TDP-43 in Endothelium as a Mediator of Blood Brain Barrier Signaling Pathway Dysfunction in Neurodegeneration.bioRxiv [Preprint]. 2023 Dec 14:2023.12.13.571178. doi: 10.1101/2023.12.13.571178. bioRxiv. 2023. PMID: 38168276 Free PMC article. Preprint.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
